The hundred slide day, and the five year look back

The most specific quality rule in American laboratory regulation

Most laboratory rules describe systems. One set describes a person, a working day, and a number.

Cytology, the microscopic examination of cells, is the only area of federal laboratory regulation with a hard daily workload cap written into the rule.

It exists because the work is visual and fatiguing, and because a missed finding on a screening slide is a specific and serious harm.

The same section carries a look-back duty that reopens years of past results, and a rescreening requirement applied to a share of everything reported as normal.

It is worth reading in full even by someone who will never have such a test. It is the clearest published example of what a regulator does when it decides human error rate is the thing to control.

Where the slides may be read, and how they are stained

The first rule is about place. "All cytology slide preparations must be evaluated on the premises of a laboratory certified to conduct testing in the subspecialty of cytology."

Reading them somewhere else, however qualified the reader, is not permitted.

Staining follows written policies. All gynecologic preparations use a Papanicolaou or modified Papanicolaou method.

Cross-contamination gets its own requirement: "Effective measures to prevent cross-contamination between gynecologic and nongynecologic specimens during the staining process must be used."

And nongynecologic specimens with a high potential for cross-contamination are stained separately, with the stains filtered or changed afterwards.

Ten percent of the normals get read again

The laboratory must run a written program designed to detect errors in performing examinations and reporting results, and the first element is a rescreen.

It requires "A review of slides from at least 10 percent of the gynecologic cases" that qualified individuals interpreted as negative for epithelial cell abnormalities and other malignant neoplasms.

The reviewer has to be senior: a qualified technical supervisor, a qualified cytology general supervisor, or a cytotechnologist who also has the general supervisor's experience.

Selection is not purely random. Cases are randomly selected from the total caseload and include negatives and cases from patients identified as having a higher than average probability of developing cervical cancer, based on available patient information.

And the timing is the part that makes it a control rather than an audit. "The review of those cases selected must be completed before reporting patient results."

So for a share of negative results, a second qualified person looked before anything was sent.

The look back that reopens five years

The second element compares what the laboratory said with what was later found.

The laboratory compares clinical information where available with its cytology reports, and compares every gynecologic report carrying a high-grade lesion, adenocarcinoma or other malignant neoplasm with the histopathology report where the laboratory has one. Causes of any discrepancy are determined.

The third element is the one patients would want to know about.

For each patient with such a current finding, the rule requires "laboratory review of all normal or negative gynecologic specimens received within the previous 5 years". It applies where the laboratory still has them on site or in storage.

And the consequence is not internal. If significant discrepancies are found that will affect current patient care, "the laboratory must notify the patient's physician and issue an amended report."

A serious finding today therefore triggers a re-examination of that patient's past normals, with a duty to correct the record if the re-examination changes it.

The statistics a laboratory has to keep on itself

Records of initial examinations and all rescreening results are documented, and once a year the laboratory produces a statistical evaluation of itself.

It counts the cytology cases examined, specimens processed by type, and patient cases reported by diagnosis, including how many were unsatisfactory for diagnostic interpretation.

It counts gynecologic cases with a serious diagnosis for which histology results were available for comparison, and cases where cytology and histology disagreed.

And it counts cases where a rescreen of a normal or negative specimen resulted in reclassification to a low-grade or high-grade lesion, adenocarcinoma or other malignant neoplasm.

Then it turns the statistics on individuals. Each person's case reviews are evaluated against the laboratory's overall statistical values, discrepancies are documented with reasons, and corrective action is taken where appropriate.

A personal limit, set by name and reassessed twice a year

Workload is not managed by a laboratory-wide policy. It is set person by person.

"The technical supervisor establishes a maximum workload limit for each individual who performs primary screening."

That limit is based on the individual's measured performance, using the rescreen of ten percent of their negative interpretations and a comparison of their interpretations against the technical supervisor's confirmations.

And it does not stand indefinitely. "Each individual's workload limit is reassessed at least every 6 months and adjusted when necessary."

So the ceiling is individual, evidence-based, and revisited twice a year.

The hundred slide cap, and the sentence protecting it

Above every individual limit sits an absolute one, and the regulation writes it with unusual force.

The maximum number of slides examined by an individual in each twenty-four hour period "does not exceed 100 slides (one patient specimen per slide; gynecologic, nongynecologic, or both) irrespective of the site or laboratory."

The phrase at the end is what gives it teeth. The count follows the person, not the employer, so working at two laboratories does not produce two allowances.

Then the sentence that anticipates how such a number gets misused: "This limit represents an absolute maximum number of slides and must not be employed as an individual's performance target."

A ceiling stated as a maximum, with an explicit instruction not to treat it as a goal, is rare in regulation and worth noticing.

A time floor sits beside it. "The maximum number of 100 slides is examined in no less than an 8-hour workday", which converts the cap into a rate rather than a quota.

Part-time readers, half slides, and one exemption

Three adjustments complete the workload rule.

For someone examining slides for less than a full day, including a full-time employee with other duties, an eight-hour period is used to prorate the number of slides that may be examined.

The regulation states that a formula is used to determine that prorated maximum. In the published electronic text the formula itself is an image rather than words, so it is not reproduced or paraphrased here.

Nongynecologic preparations made with liquid-based techniques that disperse cells over half or less of the available slide may be counted as half a slide.

And technical supervisors who perform primary screening are not required to include tissue pathology slides and previously examined cytology slides in the hundred slide count.

Records make the cap auditable. The laboratory keeps records of the total slides each individual examined in each twenty-four hour period and the hours spent, again irrespective of site or laboratory, and records documenting each individual's workload limit.

What a supervisor has to confirm before a report goes out

Certain interpretations cannot leave the laboratory on one person's reading.

A technical supervisor confirms each gynecologic preparation interpreted as showing reactive or reparative changes, or any of a listed set of epithelial cell abnormalities.

The list is granular. Squamous findings from atypical cells of undetermined significance through low-grade and high-grade lesions to squamous cell carcinoma. Glandular findings from atypical cells through adenocarcinoma in situ to several named adenocarcinomas. And other malignant neoplasms.

The confirmation has to show on the report, which must be signed to reflect the supervisory review, or carry an electronic signature authorized by the supervisor who performed it.

All nongynecologic preparations are reviewed by a technical supervisor, with the same signature requirement.

Three reporting rules follow. "Unsatisfactory specimens or slide preparations are identified and reported as unsatisfactory." "The report contains narrative descriptive nomenclature for all results." And "Corrected reports issued by the laboratory indicate the basis for correction."

The slides themselves, and who is allowed to read them

Slides are retained under the general retention rules, with two practical provisions.

They may be loaned to proficiency testing programs instead of being held for the required period, provided the laboratory gets and keeps written acknowledgment of receipt.

Loans or referrals for other purposes are documented. And whatever happens, "All slides must be retrievable upon request."

Two roles exist only in cytology. A cytology general supervisor is required, qualified either as a technical supervisor or as a cytotechnologist. That second route also demands "at least 3 years of full-time (2,080 hours per year) experience as a cytotechnologist within the preceding 10 years."

That supervisor provides day-to-day supervision, must be accessible for on-site, telephone or electronic consultation, and documents their own slide interpretations.

The documentation duty is the workload cap made personal. For each twenty-four hour period they record "the total number of slides he or she examined or reviewed in the laboratory". They also record "the total number of slides examined or reviewed in any other laboratory or for any other employer", plus the hours spent.

The cytotechnologist

The laboratory must have "a sufficient number of cytotechnologists" meeting the qualification requirements to perform the functions the rules assign them.

Qualification runs through one of two routes beyond the technical supervisor qualifications. Graduation from an accredited school of cytotechnology, or certification by an approved certifying agency. A current state license is required on top where the state requires one.

A continuity provision preserves the status of individuals who were qualified and serving as a cytotechnologist in a certified laboratory as of a stated date in December 2024 and have continued since.

The responsibilities section is short and consists entirely of records. "The cytotechnologist is responsible for documenting" their slide interpretation results for each case examined or reviewed.

And, in the same terms as the supervisor, the daily slide totals in this laboratory and in any other laboratory or for any other employer, plus the hours spent examining slides.

That cross-employer accounting is the mechanism that makes a personal daily cap enforceable at all.

What this is worth to a reader

The first thing is a fact worth carrying: a share of negative screening results were read twice, by a second and more senior person, before being reported.

The second is that a serious finding obliges the laboratory to go back through that patient's negative specimens from the previous five years, and to correct the record if that changes anything.

The third is a model. The cap follows the person rather than the employer, sets a floor on the hours it is spread over, and says explicitly that it is not a target. That is a well-designed control, and a useful comparison for any claim about throughput.

Two limits on this article. Only the cytology standard and the cytology personnel sections were read in full; the proficiency testing requirements for gynecologic cytology and the technical supervisor qualification section they cross-reference were not read for this piece.

And one element could not be read at all. The formula for prorating the slide limit across a partial working day is published as an image rather than as text, so its content is not described here.

Nothing here concerns any product sold through this site. It is included because it shows what a genuinely specific quality rule looks like.

Sources

Each document below is named as it names itself, with the date printed on that document rather than the day it was read.

1. Title 42 Code of Federal Regulations section 493.1274, Standard: Cytology, read in full for the evaluation site, staining, the ten percent rescreen, the five year look back, the annual statistics, the individual and absolute workload limits, supervisory confirmation, reporting and slide retention — Electronic Code of Federal Regulations, Office of the Federal Register, December 2023
2. Title 42 Code of Federal Regulations section 493.1467, Condition: Laboratories performing high complexity testing; cytology general supervisor, read in full — Electronic Code of Federal Regulations, Office of the Federal Register, February 1992
3. Title 42 Code of Federal Regulations section 493.1469, Standard: Cytology general supervisor qualifications, read in full for the two routes and the three year experience requirement — Electronic Code of Federal Regulations, Office of the Federal Register, December 2023
4. Title 42 Code of Federal Regulations section 493.1471, Standard: Cytology general supervisor responsibilities, read in full for the supervision duty, accessibility and the cross-employer slide records — Electronic Code of Federal Regulations, Office of the Federal Register, January 2003
5. Title 42 Code of Federal Regulations section 493.1481, Condition: Laboratories performing high complexity testing; cytotechnologist, read in full — Electronic Code of Federal Regulations, Office of the Federal Register, February 1992
6. Title 42 Code of Federal Regulations section 493.1483, Standard: Cytotechnologist qualifications, read in full for the accreditation and certification routes and the December 2024 continuity provision — Electronic Code of Federal Regulations, Office of the Federal Register, December 2023
7. Title 42 Code of Federal Regulations section 493.1485, Standard; Cytotechnologist responsibilities, read in full for the three documentation duties — Electronic Code of Federal Regulations, Office of the Federal Register, January 2003